PITTSBURGH, April 14, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that Hemanth J. Varghese has joined the Company as Chief Strategy Officer. Varghese will be a member of the ...

Viatris has agreed to a settlement in which it will pay up to $335 million to resolve opioid-related claims to state and local governments, the Pittsburgh-based generics specialist said on Monday ...

Viatris (VTRS, Financials) will pay up to $335 million in annual installments over nine years to settle opioid-related claims from U.S. states, local governments, and tribal entities, the company ...

Viatris will spend as much as $335 million to settle opioid-related claims against the Canonsburg-based pharmaceutical company. The proposed settlement over nine years would come in the form of ...

Viatris to pay up to $335 million over nine years to settle opioid claims nationwide. The company has accrued $270 million for potential resolution, noted in its 2024 10-K filing. China’s new ...

Shares of Viatris Inc. VTRS slid 3.29% to $7.36 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.57% to 4,982.77 and ...

With a market cap of $14.8 billion, Viatris Inc. (VTRS) is a global pharmaceutical company formed in 2020 through the merger of Mylan and Upjohn, a former Pfizer division. Headquartered in ...

PITTSBURGH, April 7, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) (the "Company") today announced it has reached a nationwide settlement framework to resolve opioid-related claims by states ...

Viatris to Pay up to $335 Million to Resolve Opioid-Related Claims (Reuters) -Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to resolve ...

Shares of Viatris Inc. VTRS shed 6.62% to $7.62 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 5.97% to 5,074.08 and Dow ...

Viatris (VTRS) has reached a nationwide settlement framework to resolve opioid-related claims by states, local governments, and Tribes against the Company and certain of its subsidiaries. The ...